Company Filing History:
Years Active: 1987-1989
Title: **Bradley W. Glorvigen: Innovator in Amino Acid Extraction**
Introduction
Bradley W. Glorvigen, based in Saint Paul, MN, has made significant contributions to the field of biotechnology, particularly in the extraction and purification of amino acids. With a total of two patents to his name, Glorvigen is recognized for his innovative approaches that enhance the efficiency of amino acid extraction from various aqueous mixtures.
Latest Patents
Glorvigen's latest patents focus on methods for extracting amino acids from aqueous mixtures. The first patent, titled "Extraction of Amino Acids from Aqueous Mixtures," outlines a process in which aqueous mixtures, such as fermentation broths, are contacted with an organic solution containing a water-insoluble extractant. This method not only purifies but also concentrates amino acids effectively. The second patent further expands on this technique, introducing the use of quaternary ammonium compounds as part of the extraction process. These innovations play a vital role in advancing biotechnological applications within the industry.
Career Highlights
Currently, Glorvigen is an integral member of the Henkel Corporation, a multinational company known for its strong emphasis on innovation and technology in the consumer goods and industrial sectors. His work is instrumental in advancing the company's capabilities in biotechnology and chemical engineering.
Collaborations
Throughout his career, Bradley W. Glorvigen has collaborated with notable colleagues, including Francis W. Tuominen and Ronald R. Swanson. These professional relationships have fostered a rich environment for innovation and have significantly contributed to the successful development of new extraction technologies.
Conclusion
Bradley W. Glorvigen exemplifies the innovative spirit within the field of biotechnology. His patents provide valuable methodologies for amino acid extraction, enhancing both efficiency and effectiveness. As a key player at Henkel Corporation, Glorvigen continues to drive advancements that impact various biotechnological applications, showcasing the critical role of inventors in the scientific community.